Related Experiment Videos
When is sentinel node biopsy for breast cancer contraindicated?
Helen Krontiras1, Kirby I Bland
1Department of Surgery, University of Alabama School of Medicine, Boshell Diabetes Building1808, 7th Avenue South, Birmingham, AL 35233, USA.
Surgical Oncology
|September 6, 2003
Summary
Sentinel node biopsy offers an accurate and less invasive method for axillary staging. With proper patient selection and an experienced team, this technique achieves over 95% accuracy, minimizing patient morbidity.
Area of Science:
- Oncology
- Surgical Pathology
- Surgical Oncology
Background:
- Sentinel lymph node biopsy (SLNB) is a minimally invasive technique for staging axillary lymph nodes.
- Traditional axillary lymph node dissection (ALND) carries significant morbidity.
- SLNB aims to reduce the morbidity associated with ALND while maintaining accurate staging.
Purpose of the Study:
- To review the current data on sentinel lymph node biopsy (SLNB) for axillary staging.
- To highlight the accuracy and reduced morbidity of SLNB.
- To discuss the appropriate settings and contraindications for SLNB.
Main Methods:
- Review of current scientific literature on sentinel lymph node biopsy.
- Analysis of data regarding accuracy, morbidity, and patient selection.
- Examination of contraindications for lymphatic mapping and SLNB.
Main Results:
- Sentinel node biopsy can be performed with greater than 95% accuracy.
- SLNB is appropriate in various clinical settings when patients are properly selected.
- An experienced multidisciplinary team is crucial for successful SLNB outcomes.
Conclusions:
- Sentinel node biopsy is a valuable tool for accurate and less morbid axillary staging.
- Proper patient selection and an experienced multidisciplinary team are key to achieving high accuracy.
- The review provides insights into the appropriate use and contraindications of SLNB.